What question did this study set out to answer?

The aim is to assess whether monitoring B-vitamins and homocysteine is necessary during foslevodopa/foscarbidopa therapy.

June 3, 2026Movement Disorders0 citationsOpen Access

View Full Paper

Do We Need to Monitor B‐Vitamins and Homocysteine During Initiation of Foslevodopa/Foscarbidopa Therapy?

ASAida Shaghaghi‐Zadeh MHMatthias Höllerhage FWFlorian Wegner

Key Points

The aim is to assess whether monitoring B-vitamins and homocysteine is necessary during foslevodopa/foscarbidopa therapy.
Data collected on patient demographics and characteristics.
Ethical restrictions limit public access to some data.
No specific findings or results provided in the abstract.

Abstract

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Table S1. Demographics and patient characteristics. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Do We Need to Monitor B‐Vitamins and Homocysteine During Initiation of Foslevodopa/Foscarbidopa Therapy?

Key Points

Abstract

Cite This Study

Also Consider

Also Consider